MilliporeSigma Webinars

31. How To Accelerate And Enhance ADC Therapies 6/24/2024

    Learn how payloads and advanced payload intermediates can expedite drug development and elevate ADC therapies, and explore ADC payloads, payload intermediates, and solubility-enhancing technology.

32. Make More Lentivirus And Make It Right The First Time 6/14/2024

    Discover how you can achieve higher titers and robust yield with an optimized, end-to-end lentivirus platform, designed to maximize production and quality for the success of your cell or gene therapy.

33. Filling The Sterility Testing Gap: Traceability And 21 CFR Part 11 Compliance 6/6/2024

    Watch to learn about a solution that offers digital information for every stage of a sterility test while remaining compliant with 21 CFR Part 11.

34. Strategic CMC Planning Through A Phase-Appropriate Quality Approach 5/28/2024

    A phase-appropriate quality approach ensures quality activities align with the unique risks and challenges of each development stage. Watch to learn how to apply such an approach to chemistry, manufacturing, and controls planning.

35. Unleashing The Power Of Perfusion In Intensified Processes 5/28/2024

    Explore the advantages of implementing a perfusion-specific CLD process to produce more productive clones as well as an integrated solution for intensified processing.

36. Key Quality Attributes For mRNA Drug Substance Performance 5/23/2024

    Explore the evolution of the mRNA-based therapeutics pipeline, and gain insights into the key quality attributes and associated analytics that influence mRNA performance, including best practices.

37. How To Bring Your LNP Formulation To Clinical/Commercial Manufacturing 5/23/2024

    Gain valuable insights into key considerations when selecting lipid excipients for LNP formulations and the process development steps necessary to advance them to GMP manufacturing and clinical trials.

38. An Early Formulation Screening Service 5/23/2024

    Gain insights into overcoming the challenges in lipid nanoparticle (LNP) formulation, explore critical aspects of the process and analytical development of LNPs, and much more.

39. PAT Implementation For ADC And Bioconjugation Processes 3/1/2024

    Explore expert insights into the implementation of Process Analytical Technology (PAT) for ADC and bioconjugation processes and the pros and cons of in(on)line testing for the conjugation process.

40. Advancements In Process And Payload Development 2/29/2024

    Continuous advancements in the process and payload development of ADCs and next-generation bioconjugates have the potential to progress targeted therapeutics and improve patient treatment options.